Zoledronic Acid Injection, 5.0 mg, single dose: Clinical Trials

1 trial of Zoledronic Acid Injection, 5.0 mg, single dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1

Follow Zoledronic Acid Injection, 5.0 mg, single dose: new trials by email Literature Review of Zoledronic Acid Injection, 5.0 mg, single dose trials Research Report on Zoledronic Acid Injection, 5.0 mg, single dose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of Zoledronic Acid in Patients on Dialysis
Zoledronic Acid Injection, 5.0 mg, single dose, Zoledronic Acid Injection, 2.5 mg, single dose - Chronic Kidney Disease, Osteoporosis
Phase 1Not yet recruitingUniversity of Campinas, Brazil242026-08-152026-09-10

Conditions studied

Osteoporosis (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

University of Campinas, Brazil (1)

Countries

Brazil (1)

Top investigators

Rodrigo B de Oliveira, PhD (1)